Media Releases and Opportunities
» Go to news mainMedia opportunity: Dalhousie University researchers discover existing drug can disrupt coronavirus replication, offering promise of potential antiviral
When SARS-CoV-2 began its sweep across the globe, scientists set off on a daunting quest to both develop vaccines and look for ways to treat a novel coronavirus that appeared to be highly transmissible with devastating consequences.
Those efforts included an examination of existing drugs that could be repurposed to safely and effectively treat people infected with the virus that causes COVID-19.
Virologists at Dalhousie University took on that challenge, using their work researching antivirals for influenza viruses to explore drugs that could be used in the treatment of SARS-CoV-2.
In a new paper, they describe how they discovered a new effect for an FDA-approved drug known as 6-thioguanine, or 6-TG.
In cell culture experiments, they found that the drug -- normally used in cancer therapies and the treatment of irritable bowel syndrome -- can inhibit the replication of human coronaviruses, including SARS-CoV-2. It does that by interfering with the creation of the virus's hallmark spike proteins, which are needed to penetrate the host cells and initiate infection. Without them, viruses like SARS-CoV-2 cannot interact with host cells to cause infection.
Drs. Eric Pringle and Brett Duguay, two post-doctoral fellows in Dal's Faculty of Medicine, led the research and are available to discuss their findings and how they could eventually help in the development of effective, safe treatments for future coronavirus outbreaks.
-30-
Media contact:
Alison Auld
Senior Research Reporter
Communications, Marketing and Creative Services
Dalhousie University
Cell: 1-902-220-0491
Email: alison.auld@dal.ca
Recent News
- Media opportunity: The guttural grunts, boops and high‑pitched squeals coming from under the waves now part of a digital library that could help researchers understand fish behaviors
- Media opportunity: Dalhousie project will measure GHG emissions in the municipal transportation sector with $3.6‑million grant from climate action fund
- Media opportunity: Dalhousie researchers offer guidance on building a national action plan to address violence against women
- Media opportunity: Dalhousie researchers' chance discovery could help extend battery life by replacing tape that causes self‑discharge
- Media opportunity: Unique study highlights increased involvement of the private sector in international fishery negotiations, along with sustainability outcomes over 15 years
- Media release: Early Warning to Early Action: $2.5 million gift boosts Dallaire Institute’s efforts to prevent recruitment of child soldiers
- Media opportunity: Dalhousie University research project benefits from NASA mission to gain unprecedented understanding of the Earth’s surface water and ocean topography
- Media opportunity: Research by Dalhousie University doctor reveals rise in number of seniors, people with non‑acute medical issues being left at emergency departments especially during the holidays
Comments
comments powered by Disqus